CTS Corp Reports Director Changes and Executive Compensation Updates

Ticker: CTS · Form: 8-K · Filed: 2025-11-06T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, executive-compensation, board-of-directors

TL;DR

CTS Corp shakes up board, adjusts exec pay - new director in, old one out.

AI Summary

On November 5, 2025, CTS Corporation filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the departure of a director, the election of a new director, and updates to the compensatory arrangements for certain officers. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence and stock valuation.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance matters such as director changes and executive compensation, which typically carry low inherent risk.

Key Numbers

Key Players & Entities

FAQ

Who is the departing director and what is the reason for their departure?

The filing indicates the departure of a director under Item 5.02(b), but specific names and reasons are not detailed in the provided text.

Who is the newly elected director and what is their background?

The filing mentions the election of a new director under Item 5.02(a), but their name and background are not specified in the provided text.

What specific changes were made to the compensatory arrangements of certain officers?

The filing notes updates to compensatory arrangements under Item 5.02(e), but the precise details of these arrangements are not included in the excerpt.

Are there any financial implications associated with the director changes or compensation adjustments?

The filing addresses these items under Regulation FD Disclosure and Financial Statements and Exhibits, suggesting potential financial relevance, though specific amounts are not in the provided text.

What is the SIC code for CTS Corp?

The Standard Industrial Classification (SIC) code for CTS Corp is 3672, which corresponds to PRINTED CIRCUIT BOARDS.

From the Filing

0001193125-25-268239.txt : 20251106 0001193125-25-268239.hdr.sgml : 20251106 20251106090028 ACCESSION NUMBER: 0001193125-25-268239 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251105 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251106 DATE AS OF CHANGE: 20251106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTS CORP CENTRAL INDEX KEY: 0000026058 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] ORGANIZATION NAME: 04 Manufacturing EIN: 350225010 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-04639 FILM NUMBER: 251456467 BUSINESS ADDRESS: STREET 1: 4925 INDIANA AVENUE CITY: LISLE STATE: IL ZIP: 60532 BUSINESS PHONE: 6305778800 MAIL ADDRESS: STREET 1: 4925 INDIANA AVENUE CITY: LISLE STATE: IL ZIP: 60532 8-K 1 cts-20251105.htm 8-K 8-K false 0000026058 0000026058 2025-11-05 2025-11-05   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 05, 2025     CTS CORPORATION (Exact name of Registrant as Specified in Its Charter)     Indiana 1-4639 35-0225010 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)           4925 Indiana Avenue   Lisle , Illinois   60532 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: (630) 577-8800     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, no par value   CTS   The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective November 5, 2025, the Board of Directors (the “Board”) of CTS Corporation (the “Company”) increased the size of its board from seven to eight members, and elected Kimberly MacKay to fill the resulting vacancy. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKay is also a member of the Board of the Community Foundation of New Jersey, and the Compliance, Audit and Risk Committee for BAYADA Home Health Care. As

View on Read The Filing